National Comprehensive Cancer Network

|
|
|
|
For Patients
About the NCCN Clinical Practice Guidelines in Oncology™
Recent Updates to NCCN Clinical Practice Guidelines in Oncology™
NCCN Categories of Evidence and Consensus
NCCN Guidelines Steering Committee
Submission Request to the NCCN Guidelines Panels
NCCN Guidelines Panels-Meeting Schedule
NCCN Drugs & Biologics Compendium™
About the NCCN Drugs & Biologics Compendium™
Compendium Chapters
No Longer Recommended Uses
JNCCN – The Journal of the National Comprehensive Cancer Network
Subscribe Now
FAQ
JNCCN Task Force Supplements

Clinical Recommendations

JNCCN – The Journal of the National Comprehensive Cancer Network

JNCCN – The Journal of the National Comprehensive Cancer Network is a peer-reviewed publication dedicated to improving the quality of cancer care by providing the latest information about best clinical practices, oncology outcomes, and new research initiatives to our readership. This information is provided through the publication of the NCCN Clinical Practice Guidelines in Oncology™. JNCCN also publishes review articles analyzing recommendations and detailing current oncologic practice as well as clinical research articles discussing new advances that will become standard practices in the future. Further goals are to address oncology practice at all stages and presentations, to enhance communication among oncology experts in both academic and community settings, and to provide a forum for discussion and commentary.

JNCCN is an official journal of the National Comprehensive Cancer Network (NCCN). The editorial board and associate editors include more than 44 experts in all forms of cancer and cancer care from leading cancer centers across the United States. Most members of the editorial board are also panel chairs for the NCCN Clinical Practice Guidelines in Oncology™.

JNCCN is published by Cold Spring Publishers, LLC, in Cold Spring Harbor, New York. JNCCN publishes 10 issues each year: monthly, with combined issues for May/June and November/December.

All articles except guest commentaries (which are evaluated for suitability by members of the editorial board) undergo full peer review. Reviewers are selected by the issue editors from our editorial board, guidelines panels, and the oncology community at large based on their expertise in the topic.

JNCCN is fully indexed by MEDLINE/PubMed®, Chemical Abstracts, EMBASE, EmCare, and Scopus.

Frequently Asked Questions

Is JNCCN accessible online?
How can I review for JNCCN?
What topics does JNCCN cover and how are the topics chosen?
Is JNCCN appropriate for patients and caregivers?
How do I get an individual subscription, change my address, or request JNCCN for my institution’s library?
How do I submit a manuscript to JNCCN or publish a letter to the editor?
Does JNCCN publish upcoming events or news?
Does JNCCN publish supplements or accept advertising?

Is JNCCN accessible online?

The NCCN Clinical Practice Guidelines in Oncology™ are available free online. Other content, including tables of contents, correspondence, and downloadable articles (in PDF format) are available at Ingenta, via online subscription or as individual downloads for a nominal fee. NCCN Task Force Reports are available (for individual downloads only)

How can I review for JNCCN?

Most reviewers are from our editorial board or are recommended by editorial board members. However, physicians and other experts in the field of oncologic care can submit their names as potential reviewers by e-mailing Kimberly Callan with a statement detailing their areas of interest and qualifications. Please keep in mind that our need for reviewers is limited and topic-dependent.

What topics does JNCCN cover and how are the topics chosen?

The scope of the content includes the entire spectrum of oncologic health care, ranging from prevention and screening to treatment to supportive care and including public health policy. In addition, JNCCN reports rigorous outcomes data from the world's leading cancer centers while providing a forum for correspondence and commentary. View the JNCCN Editorial Calendar

Each issue focuses on a particular area or areas of cancer or cancer care. For example, previous issues have focused on cancers of the gastrointestinal system; breast cancer screening, treatment, and prevention; and various aspects of supportive care. Topics scheduled to appear in 2008 and 2009 include breast and colon cancers, myelodysplastic syndromes, screening, and genitourinary cancers.

Our goal at JNCCN is to continually update the existing understanding of all aspects of cancer care. Therefore, we publish the complete NCCN Clinical Practice Guidelines in Oncology™ and supporting manuscripts on each topic on a rolling basis. Additionally, updates are published based on new developments and advances in the field.

The NCCN Clinical Practice Guidelines in Oncology™ are updated continually, and the most recent versions are available online. Most NCCN Guidelines will be reviewed and updated in the journal every 1 to 3 years.

Is JNCCN appropriate for patients and caregivers?

JNCCN is written mainly for clinicians and other oncology care specialists. The primary audience includes physicians, pharmacists, and oncology nurses. Information for patients, caregivers, and their families, including the NCCN Patient Summaries for People with Cancer™ (which are based on the NCCN Guidelines) are available at NCCN.com.

How do I get an individual subscription, change my address, or request JNCCN for my institution’s library?

Individual subscriptions are available in both print and online formats. For more information on subscribing, please contact our publisher, Cold Spring Publishers, LLC, at 631.424.8400, or subscribe on-line.

To change the address your individual subscription is sent to, please use our online change of address request form.

Institutional subscriptions are available in both print and online formats. Please contact our publisher, Cold Spring Publishers, LLC, at 631.424.8400 ext. 304 or www.cspubs.com.

How do I submit a manuscript to JNCCN or publish a letter to the editor?

Unsolicited original research and review articles, guest commentaries, and correspondence are welcomed, although most of the articles in the journal are invited. Please note that all full-length articles are subject to peer review and that commentaries and correspondence are evaluated for appropriateness by the editorial advisory board.

Interested authors are encouraged to contact the editorial office with questions about topics or submissions.

Information for contributors is available via e-mail and manuscripts can be submitted via e-mail.

JNCCN is committed to providing a forum to enhance collaboration among cancer care providers. We welcome comments about the Clinical Practice Guidelines in Oncology™, other articles published in the journal, or any other topic relating to cancer prevention, detection, treatment, supportive care, cancer policy, or survivorship. Please send correspondence to Kimberly Callan.

Please include affiliation and contact information in correspondence. Submission of a letter constitutes permission for publication. Letters are considered for publication as space allows, and NCCN reserves the right not to publish correspondence for any reason it deems appropriate. Letters are subject to editing and/or abridgement.

Does JNCCN publish upcoming events or news?

JNCCN publishes a calendar of events and welcomes notices of events of interest to our readership, including meetings, educational seminars, and organization support activities. Please include contact information and send notices at least 6 months in advance to Kerrin Robinson.

JNCCN does not currently include a news section.

Does JNCCN publish supplements or accept advertising?

JNCCN publishes supplements, subject to approval of the material from the editorial board. For more information regarding production times and pricing, contact David Horwitz at david@cspubs.com or call 631.424.8400, ext. 304.

The journal accepts advertising. Rate information is available. For more information or to request a media kit, contact David Horwitz at david@cspubs.com or call 631.424.8400, ext. 304.